E.U. Biotechnology Programme (Concerted Action) 1993-1995. Cell Adhesion Molecules in Neural Development and Regeneration. Contract No: BIO2-CT930326, 25 000 ECUs.
 
E.U. Biomedicine and Health Programme (Concerted Action) 1994-1996. Basic Approaches for Restoring Neuronal Function. Contract No: BMH-CT941378, 38 000 ECUs. E.U. Human Capital and Mobility Programme 1993-1994. Bioactive Peptides. Contract No: CRH-CT930286, 40 000 ECUs.
 
NATO Collaborative Research Grant 1995-1996. Neuron-Glial Interactions in Ageing and Neurodegenerative Disease, 195 000 BF.
 
Greek General Secretariat of Research and Technology Programme PENED, 1996-98. Structural and functional studies of BM88 antigen, a novel neuron-specific molecule that affects nervous system development. 8 000 000 drs.
 
R&D Franco-hellenique collaboration PLATON, 1998-1999. Genetically Engineered Cell Adhesion Molecules: Evaluation of their Potential in Nerve Regeneration. 3 500 000 drs.
 
E.U. Biotechnology and BIOMED Programmes, International Brain Research Organization (IBRO), American Multiple Sclerosis Society, Welcome Trust and the private sector, 1998. Funds raised for the realization of the 3rd European Meeting on Glial Cell Function in Health and Disease, Athens 6-10 May, 1998: 30 000 000 drs.
 
Operational Programme for Research and Technology (EPET II), 1998-2001. New Generation Sensors: Applications in airport security and biomedicine. 10 000 000 drs.
 
Career Award Programme, 1998-2001. Molecular and Cellular Mechanisms during neural development: the role of novel neuron-specific molecules in cell cycle progression, differentiation and migration. 32 000 000 drs.
 
Greek General Secretariat of Research and Technology Programme PENED ’99, 2000-2001. Factors influencing the survival and death of neuronal cells during brain development: effect of the deprivation of functional connections and the role of cell type-specific proteins. 17 000 000 drs.
 
EU Quality of Life Programme – Neurosciences, 2000-2003 Engineering neural precursors for myelin repair. Contract no; QLG3-CT-00911, 240 000 euro plus matching funds.
 
EU Quality of Life Programme – Neurosciences, 2000-2003. Genes controlling neuronal specification and differentiation. QLG3-CT-00072, 258 500 euro plus matching funds.
 
Greek General Secretariat of Research and Technology Program EPAN, 2004-2006. Neural Stem Cell Therapies for Neurodegenerative Diseases: Determination of a “molecular signature” for neuronal fate. Contract no; YB/26, 300.000 euro.
 
Greek General Secretariat of Research and Technology Programme EPAN,  2004-2006. Baculovirus Artificial Chromosomes (BVACs) and Technologies for Gene Therapy and Continuous High-Level Expression of Therapeutic Proteins in Insect Production Systems, YB11: 196 000 euro.
 
EU Training and Mobility Programme – Neurosciences, 2003-2005. Role of calcium mobilization in neuronal differentiation: novel aspects of single cell and organellar calcium signals. QLG2-CT-2002-51680: 113 000 euro.
 
Program of Greek-German collaboration IKYDA-2003, 2003-2004. Involvement of the cell adhesion molecule L1 in migration mechanisms that take place during development and regeneration of the nervous system, 10.000 euro.
 
Greek General Secretariat of Research and Technology Human Networks of Scientific and Technological Training Program, 2004-2005. Applications of light microscopy in Biomedical Research and Diagnosis, 58.213 euro together with Dr. Boleti (Molecular Virology Laboratory).
 
Institut Pasteur Paris Grand Program Horizontal (GPH), 2004-2008. Stem Cells (sub-program title: Control of Stem Cells Neurogenesis in the Adult Brain), 60.000 euro.
 
Greek General Secretariat of Research and Technology and British Council Program of Greek-English Collaboration, 2005-2006, Elucidation of the function of the neurogenic gene bm88 in a mouse knock-out model, 17.600 euro.

EMBO Short term fellowship to Maritina Sergaki, 2005, Elucidation of the function of the neurogenic gene bm88 using the knock-out model.